DK116789A - Farmaceutisk praeparat til intravaginal administrering - Google Patents

Farmaceutisk praeparat til intravaginal administrering

Info

Publication number: DK116789A
Authority: DK; Denmark
Prior art keywords: carboxylic acid; intravaginal administration; nonionic surfactant; aliphatic carboxylic; biologically active
Prior art date: 1988-03-11

Application number

DK116789A

Other languages

English (en)

Other versions

DK116789D0 (da

Inventor

Takeru Fujii

Seiichi Sako

Shigeyuki Takama

Toru Hibi

Akiya Yamada

Original Assignee

Teikoku Seiyaku Kk

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1988-03-11

Filing date

1989-03-10

Publication date

1989-11-28

1989-03-10 Application filed by Teikoku Seiyaku Kk filed Critical Teikoku Seiyaku Kk

1989-03-10 Publication of DK116789D0 publication Critical patent/DK116789D0/da

1989-11-28 Publication of DK116789A publication Critical patent/DK116789A/da

Links

239000000825 pharmaceutical preparation Substances 0.000 title 1
229940124532 absorption promoter Drugs 0.000 abstract 3
150000007933 aliphatic carboxylic acids Chemical class 0.000 abstract 3
239000002736 nonionic surfactant Substances 0.000 abstract 3
239000003945 anionic surfactant Substances 0.000 abstract 2
239000000203 mixture Substances 0.000 abstract 2
229920001184 polypeptide Polymers 0.000 abstract 2
102000004196 processed proteins & peptides Human genes 0.000 abstract 2
108090000765 processed proteins & peptides Proteins 0.000 abstract 2
102000055006 Calcitonin Human genes 0.000 abstract 1
108060001064 Calcitonin Proteins 0.000 abstract 1
108010082495 Dietary Plant Proteins Proteins 0.000 abstract 1
DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 abstract 1
125000000129 anionic group Chemical group 0.000 abstract 1
BBBFJLBPOGFECG-VJVYQDLKSA-N calcitonin Chemical compound N([C@H](C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H]([C@@H](C)O)C(=O)N1[C@@H](CCC1)C(N)=O)C(C)C)C(=O)[C@@H]1CSSC[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1 BBBFJLBPOGFECG-VJVYQDLKSA-N 0.000 abstract 1
229960004015 calcitonin Drugs 0.000 abstract 1
239000003085 diluting agent Substances 0.000 abstract 1
239000003937 drug carrier Substances 0.000 abstract 1
238000009472 formulation Methods 0.000 abstract 1
231100000252 nontoxic Toxicity 0.000 abstract 1
230000003000 nontoxic effect Effects 0.000 abstract 1
239000008194 pharmaceutical composition Substances 0.000 abstract 1
150000003839 salts Chemical class 0.000 abstract 1
235000019333 sodium laurylsulphate Nutrition 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/23—Calcitonins
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/28—Insulins
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Oil, Petroleum & Natural Gas (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Zoology (AREA)
Bioinformatics & Cheminformatics (AREA)
Reproductive Health (AREA)
Inorganic Chemistry (AREA)
Endocrinology (AREA)
Urology & Nephrology (AREA)
Gastroenterology & Hepatology (AREA)
Gynecology & Obstetrics (AREA)
Immunology (AREA)
Diabetes (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

DK116789A 1988-03-11 1989-03-10 Farmaceutisk praeparat til intravaginal administrering DK116789A (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US16716388A	1988-03-11	1988-03-11
US31550289A	1989-03-01	1989-03-01

Publications (2)

Publication Number	Publication Date
DK116789D0 DK116789D0 (da)	1989-03-10
DK116789A true DK116789A (da)	1989-11-28

Family

ID=26862907

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK116789A DK116789A (da)	1988-03-11	1989-03-10	Farmaceutisk praeparat til intravaginal administrering

Country Status (14)

Country	Link
US (2)	US5840685A (da)
EP (1)	EP0332222B1 (da)
JP (1)	JP2801249B2 (da)
KR (1)	KR0138658B1 (da)
AT (1)	ATE128874T1 (da)
AU (1)	AU617157B2 (da)
CA (1)	CA1336676C (da)
CZ (1)	CZ278971B6 (da)
DE (2)	DE68924491T2 (da)
DK (1)	DK116789A (da)
ES (1)	ES2078222T3 (da)
GR (1)	GR900300006T1 (da)
NO (1)	NO179479C (da)
NZ (1)	NZ228285A (da)

Families Citing this family (49)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5981485A (en) *	1997-07-14	1999-11-09	Genentech, Inc.	Human growth hormone aqueous formulation
JP2911496B2 (ja) *	1989-09-11	1999-06-23	帝國製薬株式会社	生理活性ポリペプチド含有高吸収性経膣剤
JPH078804B2 (ja) *	1990-08-28	1995-02-01	三菱化学株式会社	副腎皮質刺激ホルモン放出因子含有製剤
JP3628713B2 (ja) *	1993-06-07	2005-03-16	帝國製薬株式会社	生理学的に活性なペプチドを含有する膣投与製剤
ATE215382T1 (de) *	1994-12-29	2002-04-15	Mochida Pharm Co Ltd	Ulinastatin enthaltende zäpfchen
GB9516268D0 (en)	1995-08-08	1995-10-11	Danbiosyst Uk	Compositiion for enhanced uptake of polar drugs from the colon
GB2318056B (en) *	1995-08-08	1999-05-26	Danbiosyst Uk	Composition for enhanced uptake of polar drugs from the colon
US6093394A (en) *	1997-04-11	2000-07-25	Gynelogix, Inc.	Vaginal lactobacillus medicant
US8765177B2 (en)	1997-09-12	2014-07-01	Columbia Laboratories, Inc.	Bioadhesive progressive hydration tablets
US7153845B2 (en) *	1998-08-25	2006-12-26	Columbia Laboratories, Inc.	Bioadhesive progressive hydration tablets
US6043259A (en) *	1998-07-09	2000-03-28	Medicure Inc.	Treatment of cardiovascular and related pathologies
US8119159B2 (en) *	1999-02-22	2012-02-21	Merrion Research Iii Limited	Solid oral dosage form containing an enhancer
US20070148228A1 (en) *	1999-02-22	2007-06-28	Merrion Research I Limited	Solid oral dosage form containing an enhancer
US7658938B2 (en) *	1999-02-22	2010-02-09	Merrion Reasearch III Limited	Solid oral dosage form containing an enhancer
NZ514567A (en)	1999-03-08	2002-11-26	Medicure Inc	Pyridoxal analogues for vitamin B-6 disorders
EP1187639A1 (en)	1999-06-04	2002-03-20	Delrx Pharmaceutical Corporation	Formulations comprising dehydrated particles of pharmaceutical agents and process for preparing the same
US6489345B1 (en)	1999-07-13	2002-12-03	Medicure, Inc.	Treatment of diabetes and related pathologies
EP1210117A2 (en) *	1999-08-24	2002-06-05	Medicure International Inc.	Compositons for the treatment of cardiovascular diseases containing pyridoxal compounds and cardiovascular compounds
WO2001064692A1 (en)	2000-02-29	2001-09-07	Medicure International Inc.	Cardioprotective phosphonates and malonates
US7442689B2 (en) *	2000-02-29	2008-10-28	Medicure International Inc.	Cardioprotective phosphonates and malonates
US6586414B2 (en)	2000-03-28	2003-07-01	Medicure International Inc.	Treatment of cerebrovascular disease
EP1328281B1 (en)	2000-06-27	2007-08-15	Qualilife Pharmaceuticals Inc.	Compositions and methods for treating females sexual response
US6897228B2 (en)	2000-07-07	2005-05-24	Medicure International Inc.	Pyridoxine and pyridoxal analogues: new uses
US6548519B1 (en)	2001-07-06	2003-04-15	Medicure International Inc.	Pyridoxine and pyridoxal analogues: novel uses
AU7226301A (en)	2000-07-07	2002-01-21	Medicure Int Inc	Pyridoxine and pyridoxal analogues: cardiovascular therapeutics
AU2002211629A1 (en) *	2000-10-10	2002-04-22	Microchips, Inc.	Microchip reservoir devices using wireless transmission of power and data
WO2002099457A1 (en) *	2001-05-31	2002-12-12	Massachusetts Inst Technology	Microchip devices with improved reservoir opening
JP2005505429A (ja)	2001-06-28	2005-02-24	マイクロチップス・インコーポレーテッド	マイクロチップリザーバデバイスを密閉シーリングするための方法
WO2004022033A1 (en) *	2002-09-04	2004-03-18	Microchips, Inc.	Method and device for the controlled delivery of parathyroid hormone
WO2004023979A2 (en) *	2002-09-12	2004-03-25	Biosyn, Inc.	Mucus formulation for mucosal surfaces and uses thereof
US20040186077A1 (en) *	2003-03-17	2004-09-23	Medicure International Inc.	Novel heteroaryl phosphonates as cardioprotective agents
CA2523859C (en) *	2003-04-29	2011-08-02	The General Hospital Corporation	Methods and devices for the sustained release of multiple drugs
US20070219131A1 (en) *	2004-04-15	2007-09-20	Ben-Sasson Shmuel A	Compositions capable of facilitating penetration across a biological barrier
MXPA06011871A (es) *	2004-04-15	2007-10-08	Chiasma Inc	Composiciones capaces de facilitar la penetracion a traves de una barrera biologica.
US20070060549A1 (en) *	2004-08-10	2007-03-15	Friesen Albert D	Combination therapies employing ace inhibitors and uses thereof for the treatment of diabetic disorders
US7459468B2 (en)	2004-10-28	2008-12-02	Medicure International, Inc.	Aryl sulfonic pyridoxines as antiplatelet agents
CA2585165A1 (en)	2004-10-28	2006-05-18	Medicure International Inc.	Dual antiplatelet/anticoagulant pyridoxine analogs
CA2595457A1 (en) *	2005-01-25	2006-08-03	Microchips, Inc.	Control of drug release by transient modification of local microenvironments
US20080076975A1 (en) *	2005-01-25	2008-03-27	Microchips, Inc.	Method and implantable device with reservoir array for pre-clinical in vivo testing
WO2007117706A2 (en)	2006-04-07	2007-10-18	Merrion Research Iii Limited	Solid oral dosage form containing an enhancer
US20070292512A1 (en) *	2006-06-09	2007-12-20	Merrion Research Ii Limited	Solid Oral Dosage Form Containing an Enhancer
EP2288369B1 (en) *	2008-05-07	2014-07-09	Merrion Research III Limited	Compositions of gnrh related compounds and processes of preparation
CN102176900B (zh)	2008-09-17	2017-09-26	克艾思马有限公司	药物组合物和相关的给药方法
JP5409067B2 (ja) *	2009-03-23	2014-02-05	ユニ・チャーム株式会社	タンポン
WO2011120033A1 (en)	2010-03-26	2011-09-29	Merrion Research Iii Limited	Pharmaceutical compositions of selective factor xa inhibitors for oral administration
US8802114B2 (en)	2011-01-07	2014-08-12	Merrion Research Iii Limited	Pharmaceutical compositions of iron for oral administration
EP3250191B1 (en)	2015-01-29	2024-01-17	Novo Nordisk A/S	Tablets comprising glp-1 agonist and enteric coating
MA41462A (fr)	2015-02-03	2021-05-12	Chiasma Inc	Méthode de traitement de maladies
US11141457B1 (en)	2020-12-28	2021-10-12	Amryt Endo, Inc.	Oral octreotide therapy and contraceptive methods

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3888838A (en) *	1972-07-10	1975-06-10	Ayerst Mckenna & Harrison	Decapeptide having luteinizing hormone (lh)-and follicle stimulating hormone (fsh)-releasing activity, salts and compositions thereof, a process for preparing same, and intermediates therefor
JPS563846B2 (da) *	1972-10-12	1981-01-27
US4083967A (en) *	1973-11-01	1978-04-11	Burroughs Wellcome Co.	Nona- and decapeptides
US4010125A (en) *	1975-06-12	1977-03-01	Schally Andrew Victor	[D-Trp6 ]-LH-RH and intermediates therefor
US4018726A (en) *	1975-06-12	1977-04-19	Andrew Victor Schally	[D-Phe6 ]-LH-RH and intermediates therefor
IL54041A (en) *	1978-02-13	1981-05-20	Yissum Res Dev Co	Pharmaceutical compositions for enteral or vaginal application comprising the active ingredient and a nonionic surfactant
JPS55153712A (en) *	1979-05-18	1980-11-29	Kao Corp	Insulin pharmaceutical preparation and its production
US4234571A (en) *	1979-06-11	1980-11-18	Syntex (U.S.A.) Inc.	Nonapeptide and decapeptide derivatives of luteinizing hormone releasing hormone
JPS56122309A (en) *	1980-03-03	1981-09-25	Teijin Ltd	Calcitonin pharmaceutical for rectal administration
JPS5885813A (ja) *	1981-11-17	1983-05-23	Toyo Jozo Co Ltd	吸収性良好な製剤
NL193099C (nl) *	1981-10-30	1998-11-03	Novo Industri As	Gestabiliseerde insuline-oplossing.
US4659696A (en) *	1982-04-30	1987-04-21	Takeda Chemical Industries, Ltd.	Pharmaceutical composition and its nasal or vaginal use
JPS5921613A (ja) *	1982-07-28	1984-02-03	Takeda Chem Ind Ltd	直腸投与製剤
GB2127689B (en) *	1982-10-05	1986-07-09	Sandoz Ltd	Calcitonin inhalation compositions
EP0166971B1 (de) *	1984-06-09	1990-02-28	Hoechst Aktiengesellschaft	Insulinzubereitungen, Verfahren zu deren Herstellung und deren Verwendung
JPS61267528A (ja) *	1984-11-26	1986-11-27	Yamanouchi Pharmaceut Co Ltd	吸収促進剤を含有するカルシトニン経鼻剤
JPS61194034A (ja) *	1985-02-25	1986-08-28	Teijin Ltd	経鼻投与用粉末状組成物
JPS6236498A (ja) *	1985-08-09	1987-02-17	ル・エ−ル・リクイツド・ソシエテ・アノニム・プ−ル・ル・エチユド・エ・ル・エクスプルワテシヨン・デ・プロセデ・ジエオルジエ・クロ−ド	セルロ−ス保護剤
DE3603444A1 (de) *	1986-02-05	1987-08-06	Thomae Gmbh Dr K	Pharmazeutische zubereitungsformen zur stabilisierung von interferon alpha
GR871067B (en) *	1986-07-18	1987-11-19	Chugai Pharmaceutical Co Ltd	Process for producing stable pharmaceutical preparation containing granulocyte colony stimulating factor

1989
- 1989-03-09 NZ NZ228285A patent/NZ228285A/xx unknown
- 1989-03-09 NO NO891007A patent/NO179479C/no unknown
- 1989-03-10 DK DK116789A patent/DK116789A/da not_active Application Discontinuation
- 1989-03-10 CZ CS891490A patent/CZ278971B6/cs unknown
- 1989-03-10 CA CA000593354A patent/CA1336676C/en not_active Expired - Fee Related
- 1989-03-10 JP JP1058187A patent/JP2801249B2/ja not_active Expired - Fee Related
- 1989-03-11 KR KR1019890002992A patent/KR0138658B1/ko not_active IP Right Cessation
- 1989-03-13 DE DE68924491T patent/DE68924491T2/de not_active Expired - Fee Related
- 1989-03-13 AT AT89104440T patent/ATE128874T1/de active
- 1989-03-13 AU AU31253/89A patent/AU617157B2/en not_active Ceased
- 1989-03-13 DE DE198989104440T patent/DE332222T1/de active Pending
- 1989-03-13 EP EP89104440A patent/EP0332222B1/en not_active Expired - Lifetime
- 1989-03-13 ES ES89104440T patent/ES2078222T3/es not_active Expired - Lifetime
1991
- 1991-06-07 GR GR90300006T patent/GR900300006T1/el unknown
1992
- 1992-06-15 US US07/899,165 patent/US5840685A/en not_active Expired - Fee Related
1997
- 1997-11-17 US US08/971,329 patent/US5824646A/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
KR0138658B1 (ko)	1998-05-15
NO179479C (no)	1996-10-16
AU617157B2 (en)	1991-11-21
DE68924491D1 (de)	1995-11-16
JPH01294632A (ja)	1989-11-28
NO891007D0 (no)	1989-03-09
GR900300006T1 (en)	1991-06-07
CA1336676C (en)	1995-08-15
KR890014131A (ko)	1989-10-21
NZ228285A (en)	1991-08-27
JP2801249B2 (ja)	1998-09-21
EP0332222B1 (en)	1995-10-11
DK116789D0 (da)	1989-03-10
NO891007L (no)	1989-09-12
EP0332222A3 (en)	1991-03-06
AU3125389A (en)	1989-09-14
ES2078222T3 (es)	1995-12-16
ATE128874T1 (de)	1995-10-15
US5840685A (en)	1998-11-24
CZ278971B6 (en)	1994-11-16
DE332222T1 (de)	1990-03-22
DE68924491T2 (de)	1996-03-21
US5824646A (en)	1998-10-20
NO179479B (no)	1996-07-08
CZ149089A3 (en)	1994-03-16
EP0332222A2 (en)	1989-09-13

Publication	Publication Date	Title
DK116789D0 (da)	1989-03-10	Farmaceutisk praeparat til intravaginal administrering
NO883926D0 (no)	1988-09-02	Fremgangsmaate for fremstilling av stabilisert humanproteinpreparat.
NO874445L (no)	1988-04-28	Farmasoeytiske preparater av rekombinant baa-interferon samt fremstilling og formulering derav.
ATE203411T1 (de)	2001-08-15	Lagerstabile wässrige pharmazeutische zubereitungen von g-csf
DE69329651D1 (de)	2000-12-14	Wässrige arzneizusammensetzung, welche das menschliche wachstumshormon enthält
ES541521A0 (es)	1986-04-16	Un procedimiento para la preparacion de piridazinaminas.
NZ228747A (en)	1991-09-25	Stabilised pharmaceutical formulations comprising human growth hormone, glycine and mannitol
ES2071306T3 (es)	1995-06-16	El uso de tensioactivos fluorados solubles para la preparacion de formulaciones aerosoles dosificadas.
MX9302509A (es)	1994-05-31	Composiciones de polipeptidos estables en almacenamiento y metodo para su preparacion.
FR2684878B1 (fr)	1994-02-11	Composition pharmaceutique stabilisee d'il2 humaine recombinante non glycosylee sous forme reduite et son procede de preparation.
EP0056681A3 (en)	1983-07-20	Levonantradol and n-methyllevonantradol formulations
KR950701347A (ko)	1995-03-23	신규한 향종양성 사이토킨(A novel anti-neoplastic cytokine)
JPS52120192A (en)	1977-10-08	Preparation of prostaglandin

Legal Events

Date	Code	Title	Description
2001-10-29	AHB	Application shelved due to non-payment